1) Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006 Jan 1;106(1):4-16.
2) Noguchi M.: Sentinel lymph node biopsy in breast cancer: an overview of the Japanese experience. Breast Cancer. 2001;8(3):184-94.
3) Shiozawa M, Lefor AT, Hozumi Y, Kurihara K, Sata N, Yasuda Y, et al: Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer. Breast Cancer. 2013 Jul;20(3):223-9. doi: 10.1007/s12282-011-0327-9. Epub 2012 Jan 13.
4) Kimura F, Yoshimura M, Koizumi K, Kaise H, Yamada K, Ueda A, et al: Radiation exposure during sentinel lymph node biopsy for breast cancer: effect on pregnant female physicians. Breast Cancer. 2015 Sep;22(5):469-74. doi: 10.1007/s12282-013-0504-0. Epub 2013 Oct 30.
5) Koizumi M, Nomura E, Yamada Y, Takiguchi T, Takahashi K, Tada T, et al: Sentinel node detection of patients with breast cancer by radionuclide method: consideration of radiation safety. Kaku Igaku. 2001 Jan;38(1):47-52. (in Japanese with English abstract)
6) Arciero CA, Henry LR, Howard RS, Peoples GE, Bilchik AJ, Avital I, et al: Technical effects of adding 1 % lidocaine to technetium sulfur colloid for sentinel lymphatic mapping in early breast cancer: analysis of data from a double-blind randomized controlled trial. Ann Surg Oncol. 2013 Aug; 20(8):2548-55. doi: 10.1245/s10434-013-2912-y. Epub 2013 Feb 27.
7) Vu HN, O’Connor PF, Shoemaker RR, Wan W, Fratkin MJ, Bear HD: Intraoperative injection of radiocolloid for sentinel node biopsy in breast cancer. J Nucl Med Technol 2013; 41:263–267 DOI:10.2967/jnmt.113.129460
8) Makita M, Manabe E, Takei H, Kusakabe M, Sekino M: Sentinel lymph node biopsy with superparamagnetic iron oxide and a small neodymium magnet Neodymium magnet. Proceedings of the 118th Annual Congress of Japan Surgical Society SF-025-1, 2018
9) Manabe E, Makita M, Takei H, Kusakabe M , Sekino M: Acceleration by a small neodymium magnet in sentinel biopsy technique using magnetic nanoparticles and a handheld magnetometer. Proceedings of ISNS 2018, 2018
10) Okubo K, Uenosono Y, Arigami T, Matsushita D, Yanagita S, Kijima T, et al.: Quantitative assessment of fluorescence intensity of ICG in sentinel nodes in early gastric cancer. Gastric Cancer. 2018 Sep;21(5):776-781. doi: 10.1007/s10120-018-0816-z. Epub 2018 Mar 7.
11) Sekino M, Kuwahata A, Ookubo T, Shiozawa M, Ohashi K, Kaneko M et al: Handheld magnetic probe with permanent magnet and Hall sensor for identifying sentinel lymph nodes in breast cancer patients. Sci Rep. 2018 Jan 19;8(1):1195. doi: 10.1038/s41598-018-19480-1.
12) Kuwahata A, Chikaki S, Ergin A, Kaneko M, Kusakabe M, Sekino M: Three-dimensional sensitivity mapping of a handheld magnetic probe for sentinel lymph node biopsy. AIP. Adv., vol. 7, pp. 056720, 2017.
13) Rubio IT, Diaz-Botero S, Esgueva A, Rodriguez R, Cortadellas T, Cordoba O, et al: The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. Eur J Surg Oncol. 2015 Jan;41(1):46-51. doi: 10.1016/j.ejso.2014.11.006. Epub 2014 Nov 15.
14) Ahmed M, Purushotham AD, Douek M: Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014 Jul;15(8):e351-62. doi: 10.1016/S1470-2045(13)70590-4.
15) Thill M, Kurylcio A, Welter R, van Haasteren V, Grosse B, Berclaz G, et al: The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. Breast. 2014 Apr; 23(2):175-9. doi: 10.1016/j.breast.2014.01.004. Epub 2014 Jan 29.
16) Hersi AF, Eriksson S, Ramos J, Abdsaleh S, Wärnberg F, Karakatsanis A: A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery. Eur J Surg Oncol. 2018 Oct 23. pii: S0748-7983(18)31467-7. doi:10.1016/j.ejso.2018.10.064.
17) Ahmed M, Douek M.: The role of magnetic nanoparticles in the localization and treatment of breast cancer. Biomed Res Int. 2013;2013:281230. doi: 10.1155/2013/281230. Epub 2013 Jul 9.
18) Rubio IT, Diaz-Botero S, Esgueva A, Rodriguez R, Cortadellas T, Cordoba O, et al: The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. Eur J Surg Oncol. 2015 Jan;41(1):46-51. doi: 10.1016/j.ejso.2014.11.006. Epub 2014 Nov 15.
19) Derossis AM, Fey JV, Cody HS 3rd, Borgen PI: Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg. 2003 Dec;197(6):896-901.
20) Koizumi M, Nomura E, Yamada Y, Takiguchi T, Tanaka K, Yoshimoto M, et al: Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study. Nucl Med Commun. 2003 Jun;24(6):663-70. PubMed PMID: 12766602.
21) Karakatsanis A, Daskalakis K, Stålberg P, Olofsson H, Andersson Y, Eriksson S, et al: Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer. Br J Surg. 2017 Nov;104(12):1675-1685. doi: 10.1002/bjs.10606. Epub 2017 Sep 6.
22) Bass SS, Cox CE, Salud CJ, Lyman GH, McCann C, Dupont E, et al: The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg. 2001 Jan;192(1):9-16.
23) Leidenius MH, Leppänen EA, Krogerus LA, Smitten KA: The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer. Nucl Med Commun. 2004 Mar;25(3):233-8.